文献速递慢阻肺

慢性阻塞性肺疾病的CT成像:洞见、失望与前景

CT imaging of chronic obstructive pulmonary disease: insights, disappointments, and promise.
PubMed 文献 · Lancet Respir Med · 2017-09-28

本文综述了CT成像在慢阻肺中的临床应用,包括患者分层、预后判断和临床试验中间终点。尽管增进了对吸烟者肺部异质性的理解,但尚未转化为新疗法或个体化诊疗。原因涉及静态成像对肺功能的局限、临床CT分辨率不足及转化障碍,未来需新技术与数据共享。

要点

  • CT可量化评估慢阻肺患者肺结构,用于分层、预后和试验终点。
  • CT成果尚未转化为慢阻肺新治疗或个体化诊疗。
  • 需发展图像分析新技术、CT/MRI新技术及跨学科数据共享。

核心结论

  • CT成像在慢阻肺研究中提供了结构信息并用于分层和预后,但尚未转化为新疗法或个体化诊疗。

研究设计与样本

  • 综述,讨论CT成像在慢阻肺临床、流行病学和遗传学研究中的应用及局限。

主要发现

  • CT提取的数据已用于患者分层、预后判断和临床试验中间终点。
  • 这些努力增进了对吸烟者肺部疾病异质性的理解,但未带来新治疗或个体化诊疗。

临床怎么用

  • CT可用于慢阻肺患者分层和预后评估,并作为临床试验中间终点。

局限性

  • 静态成像对肺功能和功能障碍的洞察有限。
  • 临床CT扫描对肺结构微观变化的分辨率有限。
  • 生物医学界在将发现转化为治疗方面面临挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CT imaging is a readily quantifiable tool that can provide in-vivo assessments of lung structure in conditions such as chronic obstructive pulmonary disease (COPD). The information extracted from these data has been used in many clinical, epidemiological, and genetic investigations for patient stratification and prognostication, and to determine intermediate endpoints for clinical trials. Although these efforts have informed our understanding of the heterogeneity of pulmonary disease in smokers, they have not yet translated into new treatments for COPD or the personalisation of patient care. There are a multitude of potential reasons for this, including the lack of insight that static imaging provides for lung function and dysfunction, the limited resolution of clinical CT scanning for microscopic changes to the lung architecture, and the challenges that the biomedical community faces when trying to translate discovery to therapy. Such limitations might be addressed through novel image analysis techniques, up-and-coming CT-based and MRI-based technologies, closer ties between academia and industry, and an expanded endeavour to share data across the biomedical community.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Washko GR, Coxson HO, O'Donnell DE, et al. CT imaging of chronic obstructive pulmonary disease: insights, disappointments, and promise. Lancet Respir Med. 2017. PMID: 28965820. doi:10.1016/S2213-2600(17)30345-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。